
About Biosync Pharmaceuticals Private Limited
Data last updated:
Biosync Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 December 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2008PTC031442. Its GSTIN is 04AADCB6307K1ZV (Chandigarh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Bharat Bhushan Singh and Komal Thakur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf No 259 Motor Market Manimajra, Chandigarh, India – 160001.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.38 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹14.95 Lakh (net margin 2.8%) and EBITDA of ₹23.06 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
The company is associated with 3 brands: Biosync, Biohamllin Research Lab and Biosync Pharmaceuticals Pvt Ltd.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biosyncpharma.in.
Company details
Contact details
Biosync Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its website is biosyncpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressScf No 259 Motor Market Manimajra, Chandigarh, India – 160001
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Biosync Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Biosync Pharmaceuticals operates multiple associated brands including Biosync, Biohamllin Research Lab, and Biosync Pharmaceuticals Pvt Ltd. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and franchise services in India. | biosyncpharma.in | |
| Pharmaceutical manufacturing, PCD franchise, and third-party services in India. | biohamllin.com | |
| Pharmaceutical manufacturing and franchise services are offered in India. | murtelacosmetics.com |
Business activity
The main business activity of Biosync Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biosync Pharmaceuticals Private Limited, buy the company report.
Financials of Biosync Pharmaceuticals Private Limited
FY 2025 filings availableBiosync Pharmaceuticals Private Limited reported revenue of ₹5.38 Cr (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biosync Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biosync Pharmaceuticals Private Limited
Biosync Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharat Bhushan Singh Also directs: Adormus Biotech Private Limited | Director | 01 Dec 2008 | 17 Years 11 Months | Current |
| Komal Thakur Also directs: Adormus Biotech Private Limited | Director | 07 Feb 2025 | 1 Years 9 Months | Current |
Peer comparison
Biosync Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Yati Pharmaceuticals Private Limited | ₹5.39 Cr (FY 2025) | 16.0% | Muzaffarnagar, Uttar Pradesh, India | |||
| Firstmed Therapeutics Private Limited | ₹5.38 Cr (FY 2025) | -25.0% | Vanur Tk, Tamil Nadu, India | |||
| Biosync Pharmaceuticals Private Limitedthis company | ₹5.38 Cr (FY 2025) | ₹14.95 Lakh | 2.8% | -1.0% | Chandigarh, India | |
| Macheal Laboratories Limited | ₹5.37 Cr (FY 2024) | 39.0% | Gujarat, India | |||
| Upsilon Pharmaceuticals Health Care Private Limited | ₹5.37 Cr (FY 2024) | 3.0% | Gwalior, Madhya Pradesh, India | |||
| Jyoti Vishnu Pharma Private Limited | ₹5.37 Cr (FY 2025) | 3.0% | Hyderabad, Telangana, India | |||
| JPM Pharma & Chemicals Private Limited | ₹5.36 Cr (FY 2024) | 80.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Biosync Pharmaceuticals Private Limited, buy the company report.
Auditor
Biosync Pharmaceuticals Private Limited is audited by S P BABUTA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S P BABUTA & ASSOCIATES | FY 2021 | 007657N |
Shareholding
The shareholding of Biosync Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Biosync Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biosync Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biosync Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biosync Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AADCB6307K1ZV | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biosync Pharmaceuticals Private Limited, buy the company report.
Recent activity
Biosync Pharmaceuticals Private Limited has 3 board changes on record since 2008: 2 appointments and 1 cessation. The latest: Anurag Bhatia ceased to be Director on 24 Feb 2025.
Frequently asked questions
Biosync Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 December 2008 (18+ years old) and is registered under CIN U24232CH2008PTC031442.
Biosync Pharmaceuticals has 2 current directors:
- Bharat Bhushan Singh - Director
- Komal Thakur - Director
The latest financial statements of Biosync Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biosync Pharmaceuticals is 04AADCB6307K1ZV, registered in Chandigarh.
The CIN (Corporate Identification Number) of Biosync Pharmaceuticals is U24232CH2008PTC031442. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biosync Pharmaceuticals was incorporated on 01 December 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Biosync Pharmaceuticals by revenue are Yati Pharmaceuticals Private Limited, Firstmed Therapeutics Private Limited, Macheal Laboratories Limited, Upsilon Pharmaceuticals Health Care Private Limited, Jyoti Vishnu Pharma Private Limited and 1 more, all in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Anurag Bhatia ceased to be Director on 24 Feb 2025. Komal Thakur was appointed as Director on 07 Feb 2025. Bharat Bhushan Singh was appointed as Director on 01 Dec 2008.
Biosync Pharmaceuticals can be reached through the website biosyncpharma.in. Its registered office is in Chandigarh, India.
The registered office of Biosync Pharmaceuticals is at Scf No 259 Motor Market Manimajra, Chandigarh, India – 160001.
Biosync Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

